New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
09:03 EDTOREXBlue Chip says Orexigen accelerating patient enrollment for The Light Study
Blue Chip Patient Recruitment, a division of Blue Chip Marketing Worldwide, said it has partnered with Orexigen Therapeutics to accelerate patient enrollment of The Light Study, Orexigenís cardiovascular outcomes trial evaluating Contrave, an investigational medication being evaluated for the treatment of obesity. Approximately 9,000 patients will be randomized in the study within the next few weeks, nearly 14 months ahead of original forecasts, Blue Chip said.
News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
19:16 EDTOREXOn The Fly: After Hours Movers
Subscribe for More Information
14:24 EDTOREXOrexigen says EC grants marketing authorization for Mysimba
Subscribe for More Information
11:38 EDTOREXOrexigen management to meet with Leerink
Meetings to be held in Boston April 1- 2 hosted by Leerink.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use